CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Teva Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Treatment Of Solid Tumours With Rapamycin DerivativesNOVARTISFeb 18, 2016

Explore Teva Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 18, 2024Solid State Forms Of Mavacamten And Process For Preparation Thereof2
Mar 13, 2024Medical Injection Device Packaging2
Oct 6, 2021Solid State Forms Of Lumateperone Ditosylate Salt1
Nov 6, 2019Solid State Forms Of Selexipag2
Jul 17, 2019An Inhalable Medicament1
May 22, 2019An Inhalable Medicament Comprising Tiotropium1
Mar 7, 2018Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide And Methods Using Same2
Sep 27, 2017An Inhaler Comprising A Tiotropium-Containing-Composition1
Mar 22, 2017Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate2
Mar 8, 2017Solid State Forms Of Cabazitaxel And Processes For Preparation Thereof1

Top competitors of Teva Pharmaceuticals

List of top competitors of Teva Pharmaceuticals based on patent oppositions.